AbbVie Announces Topline Results from the Phase 3 INTREPID Trial Showing Lutikizumab Significantly Improved Signs and Symptoms of Disease in Patients with Hidradenitis Suppurativa

AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3 INTREPID study evaluating the safety and efficacy of lutikizumab, an investigational dual-variable-domain interleukin (IL) ...
Vietnam Investment Review

Chinese medicine manufacturer initiates clinical heart trial in Singapore

Traditional Chinese medicine producer Tong Ren Tang announced clinical trials for its flagship cardiovascular formulation ...

Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II / III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) to evaluate ivonescimab, a novel, potential first-in-class ...

Why is YouTube management outsourcing a black box? — The common sense of "invisible management" changed by SRSP

I have one question for the companies and creators who outsource their YouTube management.Are you accurately grasping what ...
creators

Vitamin D2 and D3 Are Sold as the Same Nutrient, But a Doctor Explains Why a Review of 11 Trials Found One Form Lowered the Other

A review of randomized trials found that people taking vitamin D2 had lower blood levels of vitamin D3, the form the body makes from sunlight.
oncodaily

Phase 1b/2 HERBOT Trial: First-Line HER2-Targeted Chemoimmunotherapy in Biliary Tract Cancer

First-Line HER2-Targeted Chemoimmunotherapy in Biliary Tract Cancer / Biliary tract cancer, cancer, cancer care, Cancer ...
The Print

SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease

PRNewswire Lucerne [Switzerland]/New Delhi [India], October 13: The SPARX Global Randomized Controlled Trial (RCT) has been ...
Business Insider

Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1

- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1 - 100% of participants who received encaleret reported improvements in ...

AndaSeat Pre-Black Friday Campaign Connects Phantom 4 and Xtreme With Changing Active-Workstation Design

AndaSeat Pre-Black Friday Campaign Connects Phantom 4 and Xtreme With Changing Active-Workstation Design SPOKANE, 华盛顿州, ...

The story of how a solo developer with 10 years of YouTube Shorts experience spent 1 year and 5 months building a fully autonomous growth OS (SaaS) and filed for a patent

"I'm paying hundreds of thousands of yen in outsourcing fees every month, yet my view counts are completely unstable." "I've left operations to an agency, but it's a black box and I'm worried about ...
Financial Times

Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or ...

PRINCETON, N.J.--(BUSINESS WIRE)--Sep. 25, 2026-- Bristol Myers Squibb (NYSE: BMY) today announced first time presentation of results from the prespecified analysis of the pivotal Phase 3 ...